Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal H G Duijf

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
Life Sciences|March 31, 2021
MiR-142-3p targets HMGA2 and suppresses breast cancer malignancyBehzad Mansoori, Pascal H G Duijf, Ali Mohammadi, et al.
Journal of Cellular Physiology|February 12, 2019
miR-142-3p is a tumor suppressor that inhibits estrogen receptor expression in ER-positive breast cancerBehzad Mansoori, Ali Mohammadi, Morten F Gjerstorff, et al.
Journal of Cellular Physiology|June 26, 2020
Restoration of miR-330 expression suppresses lung cancer cell viability, proliferation, and migrationAli Mohammadi, Behzad Mansoori, Pascal H G Duijf, et al.
Artificial Cells, Nanomedicine, and Biotechnology|September 12, 2017
Silencing of BACH1 inhibits invasion and migration of prostate cancer cells by altering metastasis-related gene expressionNeda Shajari, Sadaf Davudian, Tohid Kazemi, et al.
Human Molecular Genetics|April 4, 2002
Gain-of-function mutation in ADULT syndrome reveals the presence of a second transactivation domain in p63Pascal H G Duijf, Kaate R J Vanmolkot, Peter Propping, et al.
Frontiers in Genetics|April 18, 2022
Identification of Common and Distinct Pathways in Inflammatory Bowel Disease and Colorectal Cancer: A Hypothesis Based on Weighted Gene Co-Expression Network AnalysisAfshin Derakhshani, Darya Javadrashid, Nima Hemmat, et al.
Clinical Breast Cancer|August 18, 2023
MicroRNA-143-5p Suppresses ER-Positive Breast Cancer Development by Targeting Oncogenic HMGA2Behnaz Mansoori, Shiva Kiani, Alireza Ashrafi Mezajin, et al.
Journal of Cellular Physiology|June 27, 2019
miR-330 suppresses EMT and induces apoptosis by downregulating HMGA2 in human colorectal cancerBehzad Mansoori, Ali Mohammadi, Sanaz Naghizadeh, et al.
Nucleic Acids Research|December 12, 2023
The protein phosphatase EYA4 promotes homologous recombination (HR) through dephosphorylation of tyrosine 315 on RAD51Bárbara de la Peña Avalos, Nicolas Paquet, Romain Tropée, et al.
British Journal of Cancer|January 27, 2021
Correction: Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancerAmila Suraweera, Alex Duff, Mark N Adams, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
Life Sciences|March 31, 2021
MiR-142-3p targets HMGA2 and suppresses breast cancer malignancyBehzad Mansoori, Pascal H G Duijf, Ali Mohammadi, et al.
Journal of Cellular Physiology|February 12, 2019
miR-142-3p is a tumor suppressor that inhibits estrogen receptor expression in ER-positive breast cancerBehzad Mansoori, Ali Mohammadi, Morten F Gjerstorff, et al.
Journal of Cellular Physiology|June 26, 2020
Restoration of miR-330 expression suppresses lung cancer cell viability, proliferation, and migrationAli Mohammadi, Behzad Mansoori, Pascal H G Duijf, et al.
Artificial Cells, Nanomedicine, and Biotechnology|September 12, 2017
Silencing of BACH1 inhibits invasion and migration of prostate cancer cells by altering metastasis-related gene expressionNeda Shajari, Sadaf Davudian, Tohid Kazemi, et al.
Human Molecular Genetics|April 4, 2002
Gain-of-function mutation in ADULT syndrome reveals the presence of a second transactivation domain in p63Pascal H G Duijf, Kaate R J Vanmolkot, Peter Propping, et al.
Frontiers in Genetics|April 18, 2022
Identification of Common and Distinct Pathways in Inflammatory Bowel Disease and Colorectal Cancer: A Hypothesis Based on Weighted Gene Co-Expression Network AnalysisAfshin Derakhshani, Darya Javadrashid, Nima Hemmat, et al.
Clinical Breast Cancer|August 18, 2023
MicroRNA-143-5p Suppresses ER-Positive Breast Cancer Development by Targeting Oncogenic HMGA2Behnaz Mansoori, Shiva Kiani, Alireza Ashrafi Mezajin, et al.
Journal of Cellular Physiology|June 27, 2019
miR-330 suppresses EMT and induces apoptosis by downregulating HMGA2 in human colorectal cancerBehzad Mansoori, Ali Mohammadi, Sanaz Naghizadeh, et al.
Nucleic Acids Research|December 12, 2023
The protein phosphatase EYA4 promotes homologous recombination (HR) through dephosphorylation of tyrosine 315 on RAD51Bárbara de la Peña Avalos, Nicolas Paquet, Romain Tropée, et al.
British Journal of Cancer|January 27, 2021
Correction: Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancerAmila Suraweera, Alex Duff, Mark N Adams, et al.
Pageof 8